PubRank

Irene O L Ng

Author PubWeight™ 44.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene expression patterns in human liver cancers. Mol Biol Cell 2002 6.93
2 MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009 6.13
3 Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009 3.52
4 Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006 1.65
5 A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 2007 1.63
6 Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 2011 1.56
7 Molecular pathogenesis of hepatocellular carcinoma. Liver Int 2007 1.50
8 Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology 2006 1.33
9 Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res 2011 1.33
10 Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 2012 1.15
11 C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 2013 1.15
12 Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Liver Int 2015 1.11
13 PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 2004 1.05
14 Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett 2002 1.04
15 Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Clin Cancer Res 2002 1.04
16 Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res 2002 0.98
17 The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint. Exp Cell Res 2004 0.97
18 Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (<or=2 cm). J Proteome Res 2010 0.93
19 Osteomyelitis with proliferative periostitis: an unusual case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 0.92
20 Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int J Cancer 2008 0.92
21 Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma. Biochim Biophys Acta 2010 0.91
22 Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma. Liver 2002 0.89
23 Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication. Transplantation 2004 0.84
24 PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success. Pathol Oncol Res 2009 0.83
25 Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma. PLoS One 2012 0.82
26 Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment. Life Sci 2002 0.81
27 Allelic alterations in nontumorous liver tissues and corresponding hepatocellular carcinomas from chinese patients. Hum Pathol 2003 0.81
28 Galactosamine-induced fulminant liver failure--observation in a porcine model. Asian J Surg 2002 0.78
29 Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein. Liver Transpl 2011 0.78
30 Down-regulation of retinol binding protein 5 is associated with aggressive tumor features in hepatocellular carcinoma. J Cancer Res Clin Oncol 2007 0.77
31 The role of pathology and pathologists in the detection and management of cancer. Hong Kong Med J 2007 0.75
32 Fatal skin rashes and myalgia in a leukaemic patient. Haematologica 2003 0.75
33 Protein-losing enteropathy due to T-cell large granular lymphocyte leukemia. J Clin Oncol 2009 0.75
34 Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population. Transplantation 2003 0.75